94 related articles for article (PubMed ID: 1351131)
1. Taxol.
Lancet; 1992 Jun; 339(8807):1447-8. PubMed ID: 1351131
[No Abstract] [Full Text] [Related]
2. Taxol: twenty years later, the story unfolds.
Rowinsky EK; Donehower RC
J Natl Cancer Inst; 1991 Dec; 83(24):1778-81. PubMed ID: 1683907
[No Abstract] [Full Text] [Related]
3. [Taxol and ovarian adenocarcinomas].
Marty M; Extra JM; Culine S; Rousseau F
Pathol Biol (Paris); 1992 Nov; 39(9):834-5. PubMed ID: 1347165
[No Abstract] [Full Text] [Related]
4. Taxol improves outlook for lung, breast, and ovarian cancer.
Oncology (Williston Park); 1992 Aug; 6(8):16. PubMed ID: 1354469
[No Abstract] [Full Text] [Related]
5. Clinical trials referral resource. Clinical trials with taxol.
Cheson BD
Oncology (Williston Park); 1992 Mar; 6(3):67-70. PubMed ID: 1348954
[No Abstract] [Full Text] [Related]
6. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
[TBL] [Abstract][Full Text] [Related]
7. [Taxol].
Kühnle H
Zentralbl Gynakol; 1996; 118(10):580. PubMed ID: 8999717
[No Abstract] [Full Text] [Related]
8. Report from ASCO on taxol as second-line therapy for ovarian Ca.
Oncology (Williston Park); 1990 Jul; 4(7):16. PubMed ID: 1975201
[No Abstract] [Full Text] [Related]
9. [Chemotherapy of ovarian and breast cancer with Taxol].
Dtsch Med Wochenschr; 1996 Dec; 121(50 Suppl):1-12. PubMed ID: 9022362
[No Abstract] [Full Text] [Related]
10. Vitamin A intoxication during taxol therapy for refractory ovarian cancer.
Muggia FM
J Natl Cancer Inst; 1992 Sep; 84(18):1444-5. PubMed ID: 1355115
[No Abstract] [Full Text] [Related]
11. Taxol: a new and effective anti-cancer drug.
Slichenmyer WJ; Von Hoff DD
Anticancer Drugs; 1991 Dec; 2(6):519-30. PubMed ID: 1687206
[TBL] [Abstract][Full Text] [Related]
12. Euro-Canadian study with taxol hits a record.
Ann Oncol; 1992 Jun; 3(6):412. PubMed ID: 1353984
[No Abstract] [Full Text] [Related]
13. Toward a chronotherapy of ovarian cancer with taxol. Part I: Basic background.
Cornélissen G; Halberg E; Long HJ; Prem K; Bakken E; Touitou Y; Elg S; Haus E; Halberg F
Chronobiologia; 1991; 18(4):153-66. PubMed ID: 1687729
[No Abstract] [Full Text] [Related]
14. Taxol: an important new drug in the management of epithelial ovarian cancer.
Markman M
Yale J Biol Med; 1991; 64(6):583-90. PubMed ID: 1687343
[TBL] [Abstract][Full Text] [Related]
15. Taxol: a new agent active in melanoma and ovarian cancer.
Einzig AI; Wiernik PH; Schwartz EL
Cancer Treat Res; 1991; 58():89-100. PubMed ID: 1683787
[No Abstract] [Full Text] [Related]
16. Paclitaxel and docetaxel in breast and ovarian cancer.
Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
[TBL] [Abstract][Full Text] [Related]
18. [Taxol in the treatment of ovarian neoplasm].
Wang Y; Huang R; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
[No Abstract] [Full Text] [Related]
19. U-M Cancer Center embarks on ovarian cancer drug study.
Mich Med; 1992 Jun; 91(6):15. PubMed ID: 1356224
[No Abstract] [Full Text] [Related]
20. Eosinophilic ascites: taxol-induced hypersensitivity?
Kobayashi TK; Muramatsu M; Ueda M; Nishino T; Bamba M; Urabe M; Moritani S
Cytopathology; 2004 Jun; 15(3):171-2. PubMed ID: 15165278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
